These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


251 related items for PubMed ID: 19755145

  • 1. Characterisation of a live Salmonella vaccine stably expressing the Mycobacterium tuberculosis Ag85B-ESAT6 fusion protein.
    Hall LJ, Clare S, Pickard D, Clark SO, Kelly DL, El Ghany MA, Hale C, Dietrich J, Andersen P, Marsh PD, Dougan G.
    Vaccine; 2009 Nov 16; 27(49):6894-904. PubMed ID: 19755145
    [Abstract] [Full Text] [Related]

  • 2. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
    Luo Y, Wang B, Hu L, Yu H, Da Z, Jiang W, Song N, Qie Y, Wang H, Tang Z, Xian Q, Zhang Y, Zhu B.
    Vaccine; 2009 Oct 19; 27(44):6179-85. PubMed ID: 19712772
    [Abstract] [Full Text] [Related]

  • 3. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
    Li Q, Yu H, Zhang Y, Wang B, Jiang W, Da Z, Xian Q, Wang Y, Liu X, Zhu B.
    Scand J Immunol; 2011 Jun 19; 73(6):568-76. PubMed ID: 21323695
    [Abstract] [Full Text] [Related]

  • 4. Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity.
    Dietrich J, Andersen C, Rappuoli R, Doherty TM, Jensen CG, Andersen P.
    J Immunol; 2006 Nov 01; 177(9):6353-60. PubMed ID: 17056566
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immune responses and protective efficacy induced by 85B antigen and early secreted antigenic target-6 kDa antigen fusion protein secreted by recombinant bacille Calmette-Guérin.
    Shi C, Wang X, Zhang H, Xu Z, Li Y, Yuan L.
    Acta Biochim Biophys Sin (Shanghai); 2007 Apr 01; 39(4):290-6. PubMed ID: 17417685
    [Abstract] [Full Text] [Related]

  • 7. Immune responses and protective efficacy of the gene vaccine expressing Ag85B and ESAT6 fusion protein from Mycobacterium tuberculosis.
    Chang-hong S, Xiao-wu W, Hai Z, Ting-fen Z, Li-Mei W, Zhi-kai X.
    DNA Cell Biol; 2008 Apr 01; 27(4):199-207. PubMed ID: 18163878
    [Abstract] [Full Text] [Related]

  • 8. The LTK63 adjuvant improves protection conferred by Ag85B DNA-protein prime-boosting vaccination against Mycobacterium tuberculosis infection by dampening IFN-gamma response.
    Palma C, Iona E, Giannoni F, Pardini M, Brunori L, Fattorini L, Del Giudice G, Cassone A.
    Vaccine; 2008 Aug 05; 26(33):4237-43. PubMed ID: 18584925
    [Abstract] [Full Text] [Related]

  • 9. Immune responses induced by heterologous boosting of recombinant bacillus Calmette-Guerin with Ag85B-ESAT6 fusion protein in levamisole-based adjuvant.
    You Q, Wu Y, Jiang D, Wu Y, Wang C, Wei W, Yu X, Zhang X, Kong W, Jiang C.
    Immunol Invest; 2012 Aug 05; 41(4):412-28. PubMed ID: 22360290
    [Abstract] [Full Text] [Related]

  • 10. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
    Li W, Li M, Deng G, Zhao L, Liu X, Wang Y.
    Mol Med Rep; 2015 Aug 05; 12(2):3073-80. PubMed ID: 25962477
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E, Nicolle F, Clark S, Majlessi L, Boudou F, Martino A, Castello-Branco L, Leclerc C, Lewis DJ, Marsh PD, Gicquel B, Winter N.
    Vaccine; 2009 Jan 01; 27(1):28-37. PubMed ID: 18977269
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Subunit vaccine consisting of multi-stage antigens has high protective efficacy against Mycobacterium tuberculosis infection in mice.
    Xin Q, Niu H, Li Z, Zhang G, Hu L, Wang B, Li J, Yu H, Liu W, Wang Y, Da Z, Li R, Xian Q, Wang Y, Zhang Y, Jing T, Ma X, Zhu B.
    PLoS One; 2013 Jan 01; 8(8):e72745. PubMed ID: 23967337
    [Abstract] [Full Text] [Related]

  • 16. Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.
    Kolibab K, Yang A, Derrick SC, Waldmann TA, Perera LP, Morris SL.
    Clin Vaccine Immunol; 2010 May 01; 17(5):793-801. PubMed ID: 20357059
    [Abstract] [Full Text] [Related]

  • 17. [Immunity characteristics induced by a genetic vaccine expressing Ag85B-ESAT6 fusion protein].
    Shi CH, Wang XW, Zhu DS, Xu ZK, Bai YL, Xue Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Nov 01; 28(11):777-80. PubMed ID: 16324275
    [Abstract] [Full Text] [Related]

  • 18. Subunit vaccine candidate AMM down-regulated the regulatory T cells and enhanced the protective immunity of BCG on a suitable schedule.
    Luo Y, Jiang W, Da Z, Wang B, Hu L, Zhang Y, An R, Yu H, Sun H, Tang K, Tang Z, Wang Y, Jing T, Zhu B.
    Scand J Immunol; 2012 Mar 01; 75(3):293-300. PubMed ID: 22117839
    [Abstract] [Full Text] [Related]

  • 19. The development and preliminary evaluation of a new Mycobacterium tuberculosis vaccine comprising Ag85b, HspX and CFP-10:ESAT-6 fusion protein with CpG DNA and aluminum hydroxide adjuvants.
    Chen L, Xu M, Wang ZY, Chen BW, Du WX, Su C, Shen XB, Zhao AH, Dong N, Wang YJ, Wang GZ.
    FEMS Immunol Med Microbiol; 2010 Jun 01; 59(1):42-52. PubMed ID: 20298499
    [Abstract] [Full Text] [Related]

  • 20. Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis.
    Doherty TM, Olsen AW, van Pinxteren L, Andersen P.
    Infect Immun; 2002 Jun 01; 70(6):3111-21. PubMed ID: 12011005
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.